Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Sep;32(9):1456–1457. doi: 10.1128/aac.32.9.1456

Antibacterial effect of etoposide in vitro.

W Calame 1, R van der Waals 1, N Douwes-Idema 1, H Mattie 1, R van Furth 1
PMCID: PMC175891  PMID: 3196009

Abstract

Etoposide, an antitumor drug, had an effect in vitro against all strains of gram-positive bacteria studied but not against three gram-negative bacteria. The MICs ranged between 6.2 and 50 micrograms/ml. In short-term-growth experiments, etoposide had a bactericidal efficacy that was 10 to 50 times lower than that of cloxacillin.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cavalli F. VP16-213 (etoposide). A critical review of its activity. Cancer Chemother Pharmacol. 1982;7(2-3):81–85. doi: 10.1007/BF00254526. [DOI] [PubMed] [Google Scholar]
  2. Colombo T., Broggini M., Torti L., Erba E., D'Incalci M. Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice. Cancer Chemother Pharmacol. 1982;7(2-3):127–131. doi: 10.1007/BF00254534. [DOI] [PubMed] [Google Scholar]
  3. D'Incalci M., Farina P., Sessa C., Mangioni C., Conter V., Masera G., Rocchetti M., Pisoni M. B., Piazza E., Beer M. Pharmacokinetics of VP16-213 given by different administration methods. Cancer Chemother Pharmacol. 1982;7(2-3):141–145. doi: 10.1007/BF00254536. [DOI] [PubMed] [Google Scholar]
  4. Hande K. R., Wedlund P. J., Noone R. M., Wilkinson G. R., Greco F. A., Wolff S. N. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res. 1984 Jan;44(1):379–382. [PubMed] [Google Scholar]
  5. Kalwinsky D. K., Look A. T., Ducore J., Fridland A. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res. 1983 Apr;43(4):1592–1597. [PubMed] [Google Scholar]
  6. Kunst M. W., Mattie H. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J Infect Dis. 1978 Apr;137(4):391–402. doi: 10.1093/infdis/137.4.391. [DOI] [PubMed] [Google Scholar]
  7. Loike J. D., Brewer C. F., Sternlicht H., Gensler W. J., Horwitz S. B. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Res. 1978 Sep;38(9):2688–2693. [PubMed] [Google Scholar]
  8. Loike J. D., Horwitz S. B. Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. Biochemistry. 1976 Dec 14;15(25):5443–5448. doi: 10.1021/bi00670a004. [DOI] [PubMed] [Google Scholar]
  9. Mattie H., Goslings W. R., Noach E. L. Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice. J Infect Dis. 1973 Aug;128(2):170–177. doi: 10.1093/infdis/128.2.170. [DOI] [PubMed] [Google Scholar]
  10. Mattie H., van der Voet G. B. The relative potency of amoxycillin and ampicillin in vitro and in vivo. Scand J Infect Dis. 1981;13(4):291–296. doi: 10.3109/inf.1981.13.issue-4.10. [DOI] [PubMed] [Google Scholar]
  11. Mouton R. P., van Klingeren B. Standardization of antibiotic sensitivity tests. Scand J Infect Dis. 1982;14(3):243–244. doi: 10.3109/inf.1982.14.issue-3.17. [DOI] [PubMed] [Google Scholar]
  12. O'Dwyer P. J., Leyland-Jones B., Alonso M. T., Marsoni S., Wittes R. E. Etoposide (VP-16-213). Current status of an active anticancer drug. N Engl J Med. 1985 Mar 14;312(11):692–700. doi: 10.1056/NEJM198503143121106. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES